Precigen Inc is a biotechnology company that develops synthetic biology solutions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PGEN is expected to report earnings to rise 3.67% to -9 cents per share on November 12
Q3'25
Est.
$-0.09
Q2'25
Missed
by $0.01
Q1'25
Missed
by $0.10
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.01
The last earnings report on August 25 showed earnings per share of -9 cents, missing the estimate of -8 cents. With 24.21M shares outstanding, the current market capitalization sits at 1.25B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PGEN showed earnings on August 25, 2025. You can read more about the earnings report here.